Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0Veterinary and Animal Science

Kinematic changes following concurrent epidural injection with autologous conditioned serum (ACS) and glucocorticoids in dogs with cauda equina syndrome

4 affiliations
  1. 1orthoVET, Fasanenstrasse 13, Frenkendorf, CH-4402, Switzerland
  2. 2Cavia, Iwamoto 537132, Fuji, Shizuoka, 416-0901, Japan
  3. 3FHNW University of Applied Sciences Northwestern Switzerland - Campus Muttenz, Hofackerstrasse 30, 4132 Muttenz, Basel-Land, Switzerland
  4. 4Orthogen Veterinary GmbH, Ernst-Schneider-Platz 1, Düsseldorf, 40212, Germany

Abstract

Degenerative lumbosacral stenosis (DLSS) causes progressive nerve root compression, leading to cauda equina syndrome (CES) and painful gait impairments in dogs. Epidural co-administration of autologous conditioned serum (ACS) and glucocorticoids (GC) is used as a conservative intervention, but objective outcome data remain lacking. This retrospective exploratory study evaluated whether an inertial measurement unit (IMU)-based kinematic system (LupoGait) could detect gait changes following a single epidural injection of ACS and triamcinolone acetonide in 44 dogs with CES. Nominal post-treatment changes were observed in several hindlimb parameters, including stance phase (HL +0.03, 95% CI 0.005–0.05, p = 0.018), maximum gyroscope amplitude (HL +0.32, 95% CI 0.02 to 0.69, p = 0.032), and variance of the differentiated gyroscope signal (HL +0.10, 95% CI 0.01 to 0.23, p = 0.036). However, no evaluated outcomes remained statistically significant after correction for multiple comparisons. Given the uncontrolled retrospective design, these exploratory findings cannot establish therapeutic efficacy or isolate ACS-specific effects from GC administration. Nevertheless, this study demonstrates the feasibility of IMU-based kinematic analysis for objective longitudinal monitoring in dogs with CES and provides preliminary baseline data for prospective, controlled clinical trials.

Related

  1. Neural responses to conditioned threat during extinction predict concurrent and future anxiety in late adolescence
    Kubra Ulusoy, Liat Levita
    PsyArXivPreprintCC BY 4.0Full textNeuroscienceOSF
  2. DNA Methylation Alterations in Patients with Moderate-to-Severe Thyroid Eye Disease Treated with Intravenous Glucocorticoids
    Mikołaj Radziszewski, Piotr Gasperowicz, Aleksander Kuś +3
    GenesPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  3. A prefrontal–bed nucleus pathway controls aversive memory specificity independently of glucocorticoids
    Ryan T. Lingg, Shane B. Johnson, Dalton C. Hinz +7
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textNeuroscienceCrossref
  4. Glucocorticoids impair memory inference through noradrenergic disruption of GABAergic regulation in hippocampal CA3
    E. Clephas, B. Raaso, S. Spolaore +2
    bioRxivPreprintCC BYFull textNeurosciencebioRxiv
  5. Glucocorticoids in breast cancer: physiologic mechanisms and relationship to risk, survival, and treatment response.
    Robert T Chatterton, Peter H Gann
    Frontiers in endocrinologyPeer-reviewedCC BYFull textGenetics & genomicsEurope PMCCrossref
BibTeX
@article{monnier2026kinematic,
  title = {{Kinematic changes following concurrent epidural injection with autologous conditioned serum (ACS) and glucocorticoids in dogs with cauda equina syndrome}},
  author = {Patrick Blaettler Monnier and Indre Matsuzaki and Nico Gruetter and Julien Troillet},
  journal = {Veterinary and Animal Science},
  year = {2026},
  month = oct,
  doi = {10.1016/j.vas.2026.100911},
  url = {https://doi.org/10.1016/j.vas.2026.100911},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Kinematic changes following concurrent epidural injection with autologous conditioned serum (ACS) and glucocorticoids in dogs with cauda equina syndrome
AU  - Patrick Blaettler Monnier
AU  - Indre Matsuzaki
AU  - Nico Gruetter
AU  - Julien Troillet
PY  - 2026
DA  - 2026/10/20
JO  - Veterinary and Animal Science
DO  - 10.1016/j.vas.2026.100911
UR  - https://doi.org/10.1016/j.vas.2026.100911
AB  - Degenerative lumbosacral stenosis (DLSS) causes progressive nerve root compression, leading to cauda equina syndrome (CES) and painful gait impairments in dogs. Epidural co-administration of autologous conditioned serum (ACS) and glucocorticoids (GC) is used as a conservative intervention, but objective outcome data remain lacking. This retrospective exploratory study evaluated whether an inertial measurement unit (IMU)-based kinematic system (LupoGait) could detect gait changes following a single epidural injection of ACS and triamcinolone acetonide in 44 dogs with CES. Nominal post-treatment changes were observed in several hindlimb parameters, including stance phase (HL +0.03, 95% CI 0.005–0.05, p = 0.018), maximum gyroscope amplitude (HL +0.32, 95% CI 0.02 to 0.69, p = 0.032), and variance of the differentiated gyroscope signal (HL +0.10, 95% CI 0.01 to 0.23, p = 0.036). However, no evaluated outcomes remained statistically significant after correction for multiple comparisons. Given the uncontrolled retrospective design, these exploratory findings cannot establish therapeutic efficacy or isolate ACS-specific effects from GC administration. Nevertheless, this study demonstrates the feasibility of IMU-based kinematic analysis for objective longitudinal monitoring in dogs with CES and provides preliminary baseline data for prospective, controlled clinical trials.
SN  - 2451-943X
ER  -